Riskpilot← Back to searchSign inGet full accessSMARTLEGEN AS
ASActiveOrg 925589837Oscars Gate 30, 0352 OsloResidential nursing care activities · NACE 8710Est. 2020526 employees
Revenue 2024
NOK 10M
-62% vs 2023
EBITDA margin
1.2%
+107% vs 2023
Equity ratio
78.9%
Financial strength
Net profit 2024
NOK -177K
+90% vs 2023
| Revenue | NOK 10M | -62% |
| EBITDA | NOK 124K | +107% |
| Net profit | NOK -177K | +90% |
| Total assets | NOK 33,4M | +1693% |
| Equity | NOK 26,4M | +866% |
| Employees | 526 | — |
Legal name
SMARTLEGEN AS
Org number
925589837
Legal form
Aksjeselskap
NACE code
8710 · Residential nursing care activities
Founded
4. september 2020
Share capital
NOK 5 030 000
Employees
526 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Selskapets formål er å effektivisere drift av helseinstitusjoner, investering i fast eiendom og det som står i naturlig forbindelse med dette.
Address
Oscars Gate 30, 0352 Oslo
Phone
+4748291975
Email
kontakt@smartlegen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 2 478 | 25 935 | 9 954 |
| Staff expenses | −0 | −1 267 | −3 837 | −6 265 |
| EBITDA | 0 | −1 498 | −1 657 | 124 |
| Depreciation & amort. | −0 | −23 | −72 | −214 |
| EBIT | 0 | −1 521 | −1 728 | −91 |
| Net financials | 0 | −103 | −115 | −87 |
| Profit before tax | 0 | −1 623 | −1 844 | −177 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | 0 | −1 623 | −1 844 | −177 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 99 | 744 | 1 864 | 33 422 |
| Equity | 30 | −1 599 | −3 443 | 26 380 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 69 | 2 343 | 5 307 | 7 042 |
| Total debt | 69 | 2 343 | 5 307 | 7 042 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20212024
Equity ratio
78.9%
This company
38.2%
Market median
+107% vs market
20212024
Return on equity
-0.7%
This company
18.4%
Market median
-104% vs market
20212024
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
20212024
Asset turnover
0.30×
This company
1.12×
Market median
-73% vs market
20212024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-08-01 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JA Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Hecor As | Company | 99.7% | 99.7% | 2024 |
| Individual | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hecor As
SMARTLEGEN AS Board members of SMARTLEGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julie Aas Alstedt | Chief Executive Officer | 0 companies |
| Tom Erik Tidemann-Andersen | Chairman | 0 companies |
| Christine Elvenes | Board of Directors | 0 companies |